SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 448.79 |
Enterprise Value ($M) | 344.25 |
Book Value ($M) | 586.33 |
Book Value / Share | 31.02 |
Price / Book | 0.76 |
NCAV ($M) | 117.33 |
NCAV / Share | 6.21 |
Price / NCAV | 3.83 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.07 |
Return on Assets (ROA) | 0.07 |
Return on Equity (ROE) | 0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.50 |
Current Ratio | 2.00 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 279.19 |
Assets | 748.19 |
Liabilities | 161.86 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 854.50 |
Operating Income | 74.57 |
Net Income | 42.03 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 60.99 |
Cash from Investing | -213.09 |
Cash from Financing | 9.55 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Pzena Investment Management Llc | 5.50 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
53,647 | 220,785 | 24.30 | |
34,293 | 147,908 | 23.19 | |
28,512 | 143,391 | 19.88 | |
39,004 | 132,055 | 29.54 | |
(click for more detail) |
Similar Companies | |
---|---|
QGEN – Qiagen N.V. | RCUS – Arcus Biosciences, Inc. |
RFL – Rafael Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io